PTGX Stock Analysis: Buy, Sell, or Hold?
PTGX - Protagonist Therapeutics, Inc
$131.62
6.45 (5.15%)
▲
5d:
+7.33%
30d:
+41.18%
90d:
+26.96%
HOLD
MODERATE Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 05, 2026
Get Alerted When PTGX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD - EXTENDED: PTGX is 9.3% above its trading range ($120.38). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
📊 HOLD - EXTENDED: PTGX is 9.3% above its trading range ($120.38). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
In-depth Analysis How we analyze
Valuation Analysis: PTGX is currently trading at $131.62, which is considered extended relative to its 30-day fair value range of $99.18 to $120.38. From a valuation perspective, the stock is trading at a discount (Forward PE: -192.2) compared to its historical average (83.6). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, PTGX is in a strong uptrend. The price is approaching resistance at $129.74. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 5.2% recently.
Market Sentiment: PTGX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (1th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, PTGX is in a strong uptrend. The price is approaching resistance at $129.74. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 5.2% recently.
Market Sentiment: PTGX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (1th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$99.18 -
$120.38
Company Quality Score
60/100
(BUY)
Options IV Signal
1th percentile
(LOW)
Volume Confirmation
HIGH
Confidence Score
67.3%
Protect Your Profits
PTGX is technically overbought (RSI 79). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range (+9.3% above its trading range)
- BULLISH: Options cheap (IV 1th percentile)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+5.2%)
- BEARISH: Trading above Wall St target ($118.69)
- BULLISH: Market expects only 0% annual growth - appears undervalued
- CAUTION: Extended 9.3% above its trading range - wait for pullback
Trading Range Analysis
30-Day Trading Range
$99.18 -
$120.38
Current vs Trading Range
EXTENDED
Expected Move (7 Days)
±$10.47
(8.0%)
Support & Resistance Levels
Support Level
$111.17
Resistance Level
$129.74
Current Trend
Strong Uptrend
Technical data as of
Jul 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-192.23
Wall Street Target
$118.69
(-9.8%)
Revenue Growth (YoY)
99.0%
Earnings Growth (YoY)
351.3%
Profit Margin
-154.9%
PE vs Historical
-192.2 vs 83.6
CHEAP
Share & Embed Analysis
Last updated: July 02, 2026 10:39 PM ET
Data refreshes hourly during market hours. Next update: 11:39 PM
Data refreshes hourly during market hours. Next update: 11:39 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PTGX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
17
Sells
Net
INSIDERS SELLING
Recent Transactions
Asif Ali
SELL
1750 shares
2026-04-20
Arturo Md Molina
SELL
15000 shares
2026-03-26
Asif Ali
SELL
24765 shares
2026-03-26
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$27 | 55 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$412 | 59 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$197 | 54 HOLD |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$122 | 56 HOLD |
|
VRDN
Viridian Therapeutics Inc |
STRONG BUY
16 analysts |
$34 | 67 BUY |
Advanced PTGX Option Strategies
Professional options setups generated by AI based on today's PTGX price and gamma walls.
